XML 27 R15.htm IDEA: XBRL DOCUMENT v3.5.0.2
JOINT VENTURE FOR DEVELOPMENT OF APO E MIMETIC PEPTIDE MOLECULE AEM-28 AND ANALOGS (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 47 Months Ended
Aug. 03, 2012
Jun. 30, 2016
Mar. 31, 2016
Mar. 31, 2016
Jun. 30, 2016
Jun. 30, 2016
Dec. 31, 2015
Related Party Transaction [Line Items]              
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures $ 6,000,000 $ 6,000,000     $ 6,000,000 $ 6,000,000  
Joint Venture Investments In Voting Common Ownership Units (in shares) 600,000            
Joint Venture Method Investment Ownership Percentage 60.00%            
Joint Venture Investments In Non Voting Preferred Ownership Units 5,000,000            
Joint Venture Investments Common Ownership Units, Co-venture (in shares) 400,000            
Ownership Percentage Co-venture 40.00%   36.00%        
Percentage Of Royalty Payment 3.00%            
Development Activities Monthly Fee $ 63,000            
Joint Venture, Operating Expenses, Inter Company Transactions         392,000 7,782,000  
Joint Venture, Operating Expenses Allocated To Company         392,000 7,115,000  
Percentage Of Non Royalty Income 5.00%            
Conversion of Stock, Shares Converted       1,500,000      
Conversion of Stock, Shares Issued       120,000      
Management Fees   80,000          
Professional Fees   10,000          
Revolving Credit Facility [Member]              
Related Party Transaction [Line Items]              
Line of Credit Facility, Maximum Borrowing Capacity   1,500,000     1,500,000 1,500,000  
Long-term Line of Credit   1,553,000     1,553,000 1,553,000  
Common Stock [Member]              
Related Party Transaction [Line Items]              
Joint Venture Losses Recognition Criteria, Common Ownership Equity   $ 0     $ 0 $ 0  
Noncontrolling Interest, Ownership Percentage by Parent   64.00%     64.00% 64.00% 60.00%
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners   36.00%     36.00% 36.00% 40.00%
Preferred Stock [Member]              
Related Party Transaction [Line Items]              
Noncontrolling Interest, Ownership Percentage by Parent   100.00%     100.00% 100.00%  
Noncontrolling Interest [Member]              
Related Party Transaction [Line Items]              
Noncash or Part Noncash Acquisition, Other Liabilities Assumed           $ 667,000  
Maximum [Member]              
Related Party Transaction [Line Items]              
Joint Venture Method Investment Ownership Percentage         64.00%    
Minimum [Member]              
Related Party Transaction [Line Items]              
Joint Venture Method Investment Ownership Percentage         60.00%    
Exclusive License Agreement [Member]              
Related Party Transaction [Line Items]              
Annual Maintenance Payments $ 25,000            
Exclusive License Agreement [Member] | Maximum [Member]              
Related Party Transaction [Line Items]              
Milestone Payments 500,000            
Royalty Expense 1,000,000            
Exclusive License Agreement [Member] | Minimum [Member]              
Related Party Transaction [Line Items]              
Milestone Payments 50,000            
Royalty Expense 500,000            
Lipimetix [Member]              
Related Party Transaction [Line Items]              
Noncash or Part Noncash Acquisition, Other Liabilities Assumed         $ 667,000    
Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed), Total 378,000       $ 378,000    
Voting Common Ownership Units [Member]              
Related Party Transaction [Line Items]              
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures 1,000,000            
Non Voting Preferred Ownership Units [Member]              
Related Party Transaction [Line Items]              
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures $ 5,000,000